Connor-Davidson Resilience Scale: Clinical Trials

2 trials of Connor-Davidson Resilience Scale, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Connor-Davidson Resilience Scale: new trials by email Literature Review of Connor-Davidson Resilience Scale trials Research Report on Connor-Davidson Resilience Scale

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases
Connor Davidson Resilience Scale (CD-RISC 10) - Gynecologic Disease, Gynecologic Cancer
CompletedUniversity Hospital, Basel, Switzerland1322019-03-282020-06-04
Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
Insulin, insulin - Diabete Type 2, Hyperglycemia
Phase 4CompletedHospital Universitario Clinica San Rafael1162016-01-012023-03-03

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Genital Diseases, Female (1)  ·  Hyperglycemia (1)  ·  Hypoglycemia (1)

Sponsors

Hospital Universitario Clinica San Rafael (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

Switzerland (1)

Top investigators

Javier Mora (1)  ·  Viola Heinzelmann-Schwarz, Prof. Dr. MD (1)

Results publications

PMID 11889147, PMID 17513708, PMID 19158048, PMID 19719706, PMID 21228246, PMID 22223765, PMID 23435159, PMID 8422838

NIH funding

2019 (1)